Stick With uniQure N.V. (QURE). The Bull Are Alive And Well


Redmile Group LLC recently announced the acquisition of new stake in uniQure N.V. (NASDAQ:QURE). The institutional investor has increased its shareholding in the Healthcare company by 8.62% to 2.77 million shares with purchase of 0.22 million shares. This fresh investment now brings its stake to 6.49% valued currently at $124.98 million. In addition, Nantahala Capital Management LLC raised its holdings by 0.38 million to 1.71 million shares.

With over 0.6 million uniQure N.V. (QURE) shares trading Wednesday and a closing price of $40.71 on the day, the dollar volume was approximately $24.31 million. The shares have shown a negative weekly performance of -6.01% and its price on 07/22/20 lost nearly -3.53%. Currently, there are 44.28M common shares owned by the public and among those 42.01M shares have been available to trade.

An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 16 analysts who have offered their price forecasts for QURE have a consensus price objective of $75.43. The analysts have set the share’s price value over the next 12 months at a high of $90.00 and a low of $56.00 should the stock experience a downside. Incidentally, analysts’ outlook for the uniQure N.V. stock is 1.90 for the next 12 months. The average price target is 46.24% above its last price level and an upside to the estimated low will see the stock gain 27.3% over that period. But an upside of 54.77% will see the stock hit the forecast high price target while mean target price for the stock is $79.00.

Insiders at the company have transacted a total of 110 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 28 of these insider trades were purchases, accounting for 229,530 shares. Insider sales of the common stock occurred on 82 occasions, with total insider shares sold totaling 303,334 shares.

The top 3 mutual fund holders in uniQure N.V. are Federated Hermes Kaufmann Fund, Invesco Oppenheimer Global Fund, and Federated Hermes Kaufmann Small C. Federated Hermes Kaufmann Fund owns 1.87 million shares of the company’s stock, all valued at over $84.26 million. The company sold -0.23 million shares recently to bring their total holdings to about 4.38% of the shares outstanding. Federated Hermes Kaufmann Small C bought 0.16 million shares to bring its total holdings to over 0.93 million shares at a value of $42.1 million. Federated Hermes Kaufmann Small C now owns shares totaling to 2.19% of the shares outstanding.

Shares of uniQure N.V. (NASDAQ: QURE) opened at $43.11, up $0.91 from a prior closing price of $42.20. However, the script later closed the day at $40.71, down -3.53%. The company’s stock has a 5-day price change of -6.01% and -24.67% over the past three months. QURE shares are trading -41.11% year to date (YTD), with the 12-month market performance down to -38.36% lower. It has a 12-month low price of $36.20 and touched a high of $76.69 over the same period. Currently, 0.6 million shares have been traded, compared to an average intraday trading volume of 597.12K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -11.73%, -27.63%, and -28.02% respectively.

Institutional ownership of uniQure N.V. (NASDAQ: QURE) shares accounts for 96.10% of the company’s 44.28M shares outstanding. Mutual fund holders own 39.35%, while other institutional holders and individual stakeholders account for 45.28% and 12.55% respectively.

It has a market capitalization of $1.88B and a beta (3y monthly) value of 1.21. The earnings-per-share (ttm) stands at -$2.99. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.54% over the week and 5.54% over the month.

Analysts forecast that uniQure N.V. (QURE) will achieve an EPS of -$0.67 for the current quarter, $0.29 for the next quarter and -$2.13 for 2021. The lowest estimate earnings-per-share for the quarter is -$0.97 while analysts give the company a high EPS estimate of $0.27. Comparatively, EPS for the current quarter was -$0.83 a year ago. Earnings per share for the fiscal year are expected to decrease by -32.80%, and -45.90% over the next financial year.

If you are looking to buy this stock, then you may note that the average analyst recommendation by 16 brokerage firm advisors rate uniQure N.V. (QURE) as a “Strong Buy” at a consensus score of 1.90. Specifically, 11 Wall Street analysts polled rate the stock as a buy, while 4 of the 16 advise that investors “hold,” and 0 rated it as a “Sell.”

Looking at the support for the QURE, a number of firms have released research notes about the stock. Wells Fargo stated their Equal Weight rating for the stock in a research note on June 25, 2020, with the firm’s price target at $56. Robert W. Baird coverage for the uniQure N.V. (QURE) stock in a research note released on June 25, 2020 offered a Neutral rating with a price target of $58. Mizuho was of a view on June 25, 2020 that the stock is Neutral, while Goldman gave the stock Buy rating on December 03, 2019, issuing a price target of. Cowen on their part issued Outperform rating on December 03, 2019.


Please enter your comment!
Please enter your name here